Anti-SEMA3D antibody [EPR13458(B)] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal SEMA3D antibody. Carrier free. Suitable for WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 1 publication.
View Alternative Names
UNQ760/PRO1491, SEMA3D, Semaphorin-3D
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-SEMA3D antibody [EPR13458(B)] - BSA and Azide free (AB250177)
This data was developed using ab180174, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of permeabilized MCF7 cells labeling SEMA3D using ab180174 at 1/10 (red) or a rabbit IgG (negative) (green).
- WB
Supplier Data
Western blot - Anti-SEMA3D antibody [EPR13458(B)] - BSA and Azide free (AB250177)
This data was developed using ab180174, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-SEMA3D antibody [EPR13458(B)] - C-terminal (<a href='/en-us/products/primary-antibodies/sema3d-antibody-epr13458b-c-terminal-ab180174'>ab180174</a>) at 1/1000 dilution
Lane 1:
293T cell lysate at 10 µg
Lane 2:
Fetal brain lysate at 10 µg
Lane 3:
MCF7 cell lysate at 10 µg
Lane 4:
Fetal heart lysate at 10 µg
Secondary
All lanes:
Standard HRP labeled goat anti-rabbit at 1/2000 dilution
Predicted band size: 90 kDa
true
Related conjugates and formulations (1)
-
Anti-SEMA3D antibody [EPR13458(B)] - C-terminal
Reactivity data
Product details
ab250177 is the carrier-free version of ab180174.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SEMA3D influences axonal guidance angiogenesis and immune response. It participates as part of a complex with its receptors regulating signaling pathways that are important for nervous system development and vascular patterning. By altering cellular processes SEMA3D can impact how cells grow connect and interact within their environment affecting tissue morphogenesis and repair.
Pathways
SEMA3D interacts with the semaphorin signaling pathway and the VEGF (vascular endothelial growth factor) pathway. These pathways are essential for processes such as axon guidance and blood vessel formation. SEMA3D works closely with proteins like Plexin-A1 and Neuropilin-1 orchestrating cellular responses necessary for vascular and neural network development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Experimental and therapeutic medicine 23:157 PubMed35069838
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com